Welcome Dr. Meghan Chenoweth

We would like to welcome Dr. Meghan Chenoweth (Assistant Professor, Department of Pharmacology and Toxicology, Department of Psychiatry, University of Toronto), to the CPIN Program. Dr. Meghan Chenoweth is studying intersections between genetics, sex and gender, substance use, and concurrent psychiatric disorders. Dr. Chenoweth leverages genome-wide approaches, sex-based analysis, and biomarkers to answer her research questions.
Examples of current projects include:
a) Identifying pharmacogenomic predictors of smoking cessation medication efficacy and side effects
b) Investigating the shared genetic liability for substance use and concurrent psychiatric disorders, and
identifying new biological targets for drug discovery
c) Discovering and functionally characterizing novel variants in genes involved in nicotine metabolism
d) Examining genetic risk factors for substance use, including cigarettes and electronic cigarettes (i.e. vapes), in youth
Dr. Chenoweth’s work is funded by the Canadian Institutes of Health Research and the National Institutes of Health.